Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Breast Cancer Research and Treatment
Published November 14, 2026
Survival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-ne...
November 15, 2026
Medspoke
Medspoke
Kidney International Reports
Published October 7, 2026
00:00
--:--
Clinical Trial of Open-Label Mezagitamab in IgAN: Final 96-Week Results.
November 15, 2026
Share
Clinical Trial of Open-Label Mezagitamab in IgAN: Final 96-Week Results.
https://www.medspoke.co/channel_journal?id=685&tap_id=17690
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Nephrology Dialysis Transplantation (NDT)
Published November 14, 2026
Urinary peptidomic classifier for the non-invasive diagnosis of Alport syndrome.
November 15, 2026
Why are you reporting this TALK?